Actualization of knowledge about the state of measurement of 25-hydroxyvitamin D in serum. A mini-review 2015 – 2016.
Authors:
B. Friedecký; J. Vávrová
Authors‘ workplace:
ÚKBD Fakultní nemocnice, Hradec Králové
Published in:
Klin. Biochem. Metab., 24, 2016, No. 1, p. 10-13
Overview
Objective:
Actualization of statement in 25-hydroxyvitamin D measurement
Method:
Information from websites and other documents of international vitamin D standardization program VDSP and from recent publications deals with 25-hydroxyvitamin D measurements in human serum
Results:
After 1 year we can see that effect of international standardization program VDSP is negligible both in precision and bias values. Significantly higher problems with analytical quality show immunochemical methods than separate measurements. Standardization process VDSP continues in 2015-2016 by study of the commutability experiments.Their target is to create highly commutable control materials for CAP and DEQAS programs, assured reliable verification of standardization level in routine and research clinical laboratories. Many recent publications are devoted to assessment of components, negatively influenced the results of 25-hydroxyvitamin D measurements in serum samples. Objects of interest are namely 25-hydroxyvitamin D2 and its level of cross immunoreaction, influence on bias level by 24, 25-dihydroxyvitamin D content, problems with 3-epi-25-hydroxyvitamin D3, and also with vitamin D bound protein (VDSP). These influences, resulted to elevated bias values are much more frequented in immunochemical methods than in separate methods and are in different immunochemical methods very different.
Discussion:
Risk of increased bias values namely in immunochemical methods can decreased reliability of classification of deficiency by vitamin D in individual patients. It also can be the source of problems in analysis of children due to high concentration of 3-epi-25-hydroxyvitamin D3 and in analysis of dialyzed patients due to problems with VDBP.
Keywords:
VDSP; VDBP; 25-hydroxyvitamine D; 25-hydroxyvitamine D2; 24, 25-dihydroxyvitamine D; 3-epi hydroxyvitamin D3.
Sources
1. Tai, S. S., Bedner, M., Phiney, K. W. Development of a candidate reference measurement perocedure for the determination of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in human serum using isotope-dilution liquid chromatography-tandem mass spectrometry. Anal. Chem., 2010, 82, p. 1942-8.
2. Stepman, H. C. M., Vanderroost, A., Uytfanghe, K. V., Thienpont, L. M. Candidate reference measurement procedures for serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 by using isotope-dilution liquid chromatography-tandem mass spectrometry. Clin. Chem., 2011, 57, p. 441-8.
3. Camara, J., Hoofnagle, A., Carter, G., Sempos, CH. Take Two: Gearing Up for the Next Vitamin D Commu-tability Commutability Study. Clin. Lab. News, Feb 2015
4. Stockl, D., Sluss, P. M., Thienpont, L. M. Specification for trueness and precision of a reference measurement system for serum/plasma 25-hydroxyvitamin D assays. Clin. Chim. Acta, 2009, p. 4088-13.
5. Moreau, E., Bächer, S., Mery, S., Le Goff, C., Piga, N., Vogeser, H. et al. Performance characteristic of the VIDAS 25-OH vitamin D assay-comparison with four immunoassays and two liquid chromatography-tandem mass spectrometry method in a multicentric study. Clin. Chem. Lab. Med., 2016, 54, p. 45-53
6. Saleh, L., Mueller, D., von Eckardstein, A. Analytical and clinical performance of the new Fujirebo 25-OH vitamin D assay:a comparison with liquid chromatography-tandem mass spectrometry and three other automated assays. Clin. Chem. Lab. Med., 2015, DOI 10.1515/cclm-2015-0427
7. Black, L. J., Anderson, D., Clarke, H. W., Poisonby, A. L., Lucas, R. M. Analytical bias in the measurement of serum 25-hydroxyvitamin D concentration impairs assessment of vitamin D status in clinical and research settings. Plos One, 2015, 10, DOI: 10.1371/journal pone.0135478
8. Cashman, K. D., Hayes, A., Galvin, K., Merkel, J., Jones, G., Kaufmann, H. et al. Significance of serum 24, 25-dihydroxyvitamin D in the assessment of vitamin D status: a double-edged sword. Clin. Chem., 2015, 61, p. 636-645
9. Heijboer, A. C., Blankenstein, M. A., Kema, I. P., Buijs, M. M. Accuracy of 6 routine 25-hydroxyvitamin D assays:influence of vitamin D binding protein. Clin. Chem., 20012, 58, p. 543-548.
10. Depreter, B., Heijboer, A. C., Langlois, M. S. Accuracy of three automated 25-hydroxyvitamin D assays in hemodialysed patients. Clin. Chim. Acta, 2013, 415, p. 255-260.
Labels
Clinical biochemistry Nuclear medicine Nutritive therapistArticle was published in
Clinical Biochemistry and Metabolism
2016 Issue 1
Most read in this issue
- Antibody structure and its reactivity.
- Criteria of analytical quality measurement in clinical biochemistry. Current international consensus and its implications for routine action of clinical laboratories.
- Influence of IGF1 (insulin-like growth factor 1) signaling pathway to the development of cancer diseases
- IGF1 (insulin-like growth factor 1), basic characteristics, biological effect, age and gender dependence